Anticipated $2.68 EPS for Thermo Fisher Scientific Inc. (TMO) on July, 25

June 26, 2018 - By Matthew Medley

Thermo Fisher Scientific Inc. (NYSE:TMO) Corporate Logo
During Q1 2018 the big money sentiment decreased to 0.86. That’s change of 0.05, from 2017Q4’s 0.91. 42 investors sold all, 444 reduced holdings as Thermo Fisher Scientific Inc. ratio worsened. 301 rose stakes while 119 funds bought stakes. Funds hold 331.98 million shares thus 1.09% less from 2017Q4’s 335.65 million shares.
Boston Private Wealth Limited Liability Company stated it has 0.05% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO). Carderock owns 28,457 shs for 2.59% of their capital. Loeb Corp reported 3,380 shs. Girard Ptnrs has invested 0.97% in Thermo Fisher Scientific Inc. (NYSE:TMO). Chilton Inv Ltd Liability invested in 0.49% or 62,071 shs. Qs Limited Com holds 18,400 shs. First Midwest Bancorporation Trust Division holds 0.33% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO) for 11,583 shs. Viking Ltd Partnership has invested 1.08% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO). Monetary Grp Inc Incorporated invested 1.44% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO). Btim has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Perkins Coie Trust, a Washington-based fund reported 532 shs. Hilltop stated it has 3,228 shs. Sit Invest Associate accumulated 0.18% or 35,892 shs. Omega Advisors holds 207,400 shs. Moreover, Jp Marvel Advsr Ltd Liability Co has 3.14% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 49,334 shs.

Thermo Fisher Scientific Inc. registered $48.68 million net activity with 0 insider buys and 11 selling transactions since February 2, 2018. Shares for $9.67 million were sold by CASPER MARC N on Friday, June 15. Another trade for 6,000 shs valued at $1.31 million was sold by Durbin Patrick M. Parrett William G sold $211,430 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 1,000 shs on Friday, February 23. On Friday, February 2 Herrema Gregory J. sold $7.32M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 33,327 shs. 206 shs were sold by HARRIS C MARTIN, worth $44,174 on Friday, May 18.

Thermo Fisher Scientific Inc. (NYSE:TMO) is awaited to announce earnings on July, 25., according to RTT. Analysts have anticipation on stock’s earnings per share of $2.68. That’s up 16.52 % from last year’s $2.3 earnings per share. The profit will be $1.08 billion for TMO if $2.68 earnings per share becomes true. After $2.50 EPS report previous quarter, Wall Street now sees 7.20 % EPS growth of Thermo Fisher Scientific Inc.. TMO is touching $205.39 during the last trading session, after increased 0.22%.Currently Thermo Fisher Scientific Inc. is uptrending after 23.57% change in last June 26, 2017. TMO has 123,335 shares volume. The stock outperformed the S&P 500 by 11.00%.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

In total 9 analysts cover Thermo Fisher (NYSE:TMO). “Buy” rating has 8, “Sell” are 0, while 1 are “Hold”. (NYSE:TMO) has 89% bullish analysts. 12 are the (NYSE:TMO)’s ratings reports on Jun 26, 2018 according to StockzIntelligence Inc. In Wednesday, January 31 report Robert W. Baird maintained it with “Buy” rating and $236.0 target. In Wednesday, January 31 report Cowen & Co maintained the stock with “Buy” rating. On Thursday, February 1 Morgan Stanley maintained Thermo Fisher Scientific Inc. (NYSE:TMO) with “Overweight” rating. On Wednesday, April 11 the firm has “Overweight” rating given by Morgan Stanley. On Thursday, February 1 Leerink Swann maintained the shares of TMO in report with “Buy” rating. In Thursday, April 26 report Morgan Stanley maintained it with “Overweight” rating and $230 target. On Thursday, January 18 the stock has “Buy” rating by Robert W. Baird. On Thursday, February 1 the rating was maintained by Bank of America with “Buy”. The stock rating was maintained by Barclays Capital with “Overweight” on Thursday, February 1. On Thursday, February 1 the firm has “Hold” rating by Jefferies given.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.The firm is worth $82.63 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets.36.53 is the P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

A couple more Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: which released on June 26, 2018 “Diagnostics Play Critical Role in Medical Sector”, also on June 25, 2018 published “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …”, the next is “Thermo Fisher Scientific Inc (TMO) CEO Marc N Casper Sold $9.7 million of Shares” on June 19, 2018. has article titled “Thermo Fisher launches Ion AmpliSeq HD technology”.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.